Portfolio company
ExonHit
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops in vitro diagnostic tests and drug discovery solutions using RNA splicing technology for researchers and healthcare professionals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genomic Vision
This company develops molecular combing technology and DNA analysis tools for researchers and clinicians in diagnostic and drug discovery sectors.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Ischemia Technologies
This company develops and manufactures in vitro diagnostic products for cardiovascular and acute care medicine to assist clinicians in detecting cardiac ischemia.
Epigenica
This company develops epigenetic analysis kits and screening tools for researchers in drug discovery, diagnostics, and precision medicine.
DENCODA
This biotechnology company develops DNA-linked probes and diagnostic assays for researchers and healthcare providers to detect disease biomarkers and enzyme activities.
4BASES
This company develops diagnostic genetic testing kits and sequencing reagents for healthcare professionals and clinical laboratories to support precision medicine and disease prevention.
MultiplexDX
This company develops molecular diagnostic tests and reagents for oncologists and research institutions to improve cancer profiling and infectious disease detection.
Plexigen
This company develops biochips and instrumentation for genomic and proteomic testing to serve clinical research and diagnostic laboratories.
